Valeo Pharma Inc T.VPH

Alternate Symbol(s): T.VPH.DB | VPHIF

Healthcare

Valeo Pharma Inc. is a Canadian pharmaceutical company. The Company acquires, or in-licenses branded pharmaceuticals and hospital specialty products for sale in Canada. The Company is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Its respiratory/allergy products include Enerzair Breezhaler, Atectura Breezhaler and Allerject. The ophthalmology products include Xiidra and Simbrinza. Its specialty products include Redesca, Onstryv, M-Eslon, Yondelis and Ametop Gel 4%. The Company's wholly owned subsidiary is VPI Pharmaceuticals Inc.

TSX:VPH - Post by User

Valeo Pharma Inc > RBC Analyst -FMV $1.72

<< Previous

Bullboard Posts

Next >>

Post by kooter33on Mar 02, 2021 3:38pm

177 Views

Post# 32697378

RBC Analyst -FMV $1.72

Analyst Research and Ratings

Though VPH has outperformed its Major Drugs peers over the past year, over the last three months it has lagged behind its peers.

Morningstar's Take

Morningstar's Take
Morningstar Rating	3 stars out of 5 starsQ
Quantitative Valuation	Undervalued
Fair ValueQ	1.72 CAD
Last price as of Mar 01, 2021	1.18 CAD
Quantitative Uncertainty	Extreme
Economic Moat	--
Market Cap	68.5 M
Country of Domicile	Canada